OBJECTIVES: To compare the clinical and biologic features at diagnosis between sporadic
and familial clinically localized prostate cancer (CaP), and to compare the prognosis of …

Objective: We evaluated if epidemiological features of familial prostate cancer are
associated with certain clinical or histopathological characteristics of the disease. Methods …

OBJECTIVE: The outcome of prostate cancer (CaP) patients treated with radical
prostatectomy (RP) might be influenced by family history (FH) in a subset of patients. We …

BACKGROUND Familial prostate cancer (CaP) accounts for 15–20% of all CaP, and
hereditary CaP for 5–10% of patients. Few data are available concerning their clinical and …

Purpose: There are conflicting reports concerning whether prostate cancer in families with
multiple affected members has different clinical and pathological features than sporadic …

OBJECTIVE:: To evaluate the clinical impact of different definitions of hereditary prostate
cancer (PCa), the relative risk (RR) of relatives of PCa cases and differences in clinical …

Purpose: We analyzed the outcome after radical prostatectomy of patients with familial
prostate cancer versus patients with sporadic prostate cancer. Materials and Methods: The …

Background We investigated prevalence of familial and hereditary prostate cancer (PCa) in
Asian population, and compared clinical characteristics between familial and sporadic …

BACKGROUND The definition of hereditary prostate cancer (HPC) is based on family history
and age at onset. Intuitively, HPC is a serious subtype of prostate cancer but there are only …

Abstract Study Type-Aetiology (cohort) Level of Evidence 2b OBJECTIVE• To describe
clinical and histopathological characteristics of Finnish familial prostate cancer (PCa) …